New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Chr. Hansen signs agreement to acquire Medipharm from Arla Foods

Today Chr. Hansen and Arla Foods AB signed a conditional agreement on Chr. Hansen’s acquisition
of the Swedish Arla Foods' subsidiary Medipharm AB. Medipharm specializes in probiotic bacterial
solutions for the agricultural and food industries and has subsidiaries in the US, the Czech Republic
and Hungary with a total of almost 100 employees and sales close to SEK 130 million.

The acquisition of Medipharm will strenghten Chr. Hansen’s activities in probiotic cultures - an area
where Chr. Hansen holds a market leader position. Put together with the knowledge within Chr.
Hansen on lactic acid bacteria the acquisition will create an opportunity to further grow this
business area.

“We are most satisfied with this agreement. Cultures are very important to us and over the past
years we have experienced quite high growth in this business area. We see the agreement to
acquire Medipharm as a natural step in further accelerating the growth within cultures. The
agreement further substantiates our strategic focus on developing new and exciting applications
with probiotic cultures within the animal health as well as human health areas. We will spend the
coming time on getting a thorough overview of all details and then draw up a plan for the future,"
says Lars Frederiksen, CEO, Chr. Hansen.

Also Arla Foods is content with the agreement with Chr. Hansen.

“In recent years Arla Foods has strengthened its focus on core activities and the divestment of
Medipharm represents a natural step in this development. We are quite pleased to sign an
agreement with a specialist company like Chr. Hansen, which we are sure will provide the best
possible opportunities for growth and development," says Peder Tuborgh, CEO, Arla Foods.
The final closing of the agreement is expected to take place at the beginning of 2008.
The price is not disclosed.

For further information, please contact:
Lars Wodschow, Director, Communications & PR, Chr. Hansen
Tel.: +45 4574 7620
Mobile: +45 4097 8193

About Chr. Hansen
Chr. Hansen is a global biotechnology company that provides ingredients to the food, dairy, human
and animal health and nutrition industries. The company is a leading supplier of cultures,
probiotics, enzymes, colors, flavors and seasonings, which are applied in foods and beverages,
dietary supplements, and agricultural products.
For more information please visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.